Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Ozempic
Read More
Novo Nordisk Rolls out Ozempic in India at ₹2,200 per Week Amid Patent Disputes
Novo Nordisk, the Denmark-based pharmaceutical major, has formally introduced its widely used diabetes and weight-management drug Ozempic in the Indian…
Ozempic and Wegovy Linked to Rare Eye Condition Resulting in One-Eye Blindness
A recent study has identified a potential link between the popular diabetes and weight-loss drugs Ozempic and Wegovy and a…